Need professional-grade analysis? Visit stockanalysis.com
$17.40M
N/A
N/A
N/A
Medicus Pharma Ltd. Common Stock (MDCX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.33, down 2.04% from the previous close.
Over the past year, MDCX has traded between a low of $0.30 and a high of $7.78. The stock has lost 91.6% over this period. It is currently 95.7% below its 52-week high.
Medicus Pharma Ltd. Common Stock has a market capitalization of $17.40M.
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.
Side-by-side comparison against top Healthcare peers.